The American Journal of Digestive Diseases

, Volume 11, Issue 7, pp 522–535

Esophageal motor abnormalities in scleroderma and related diseases

  • Thomas A. Saladin
  • Arthur B. French
  • Chris J. D. Zarafonetis
  • H. Marvin Pollard


Esophageal motor activity was measured by intra-esophageal pressure recordings in 53 patients with scleroderma and 29 patients with other collagen diseases. The purpose of the study was to determine the relationship of motor abnormalities to esophageal symptoms, to compare the abnormalities in scleroderma with those in other collagen diseases, and to try to increase understanding of the responsible mechanism. Methacholine was given to 36 of the 53 patients with scleroderma to confirm that the Mecholyl test is negative in scleroderma and to see whether intraluminal pressure changes accompany the resulting improvement in esophageal emptying.

Abnormalities in the intraluminal pressure response of the esophagus to deglutition were seen in 79% of the patients with scleroderma. Of those with an abnormal swallowing pattern, 62% showed diminution or absence of the lower esophageal sphincter pressure zone. Although changes in swallowing pattern did not correlate with esophageal symptoms, absence of lower esophageal sphincter pressure did. The 29 patients with other collagen diseases had similar but less severe abnormalities in the motor response to deglutition. Usually there was better preservation of the lower esophageal sphincter. Neither abnormality correlated with esophageal symptoms in this group.

The Mecholyl test was negative in patients with scleroderma. No significant change was found in the pressure studies after methacholine.

Of the 66 patients who had both X-ray and manometric studies of the esophagus, intraluminal pressure studies showed aperistalsis in all patients without peristalsis on X-ray studies as well as in 18 patients who appeared to show normal esophageal peristalsis on X-ray studies.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ehrmann, S. Ueber die Beziehung der Sklerodermie zu den autotoxischen Erythemen.Wien Med Wschr 53:1098 (and 1156), 1903.Google Scholar
  2. 2.
    Schmidt, R. Diskussion vom 11. Februar 1916. Wissenschaftliche Gesellschaft deutscher Aerzte in Boehmen: Sklerodermie mitt Dysphagie.Wien Klin Wschr 29: 932, 1916 (Deut Med Wch42:1023, 1916).Google Scholar
  3. 3.
    Helm, F. Seltene Roentgenbilder des Oesophagus.Medizinische Klinik (Juli-Dez): 665, 1918.Google Scholar
  4. 4.
    Schwarz, P. Sklerodermie und Roentgenkastration.Schweiz Med Wschr 7:246, 1926.Google Scholar
  5. 5.
    Nomland, R. Sclerodactyla with calcification.AMA Arch Derm 21:322, 1930.Google Scholar
  6. 6.
    Fessler, A., andPohl, R. Stenosierender Prozess des Esophagus bei Sklerodermie.Derm Z 63: 164, 1931.Google Scholar
  7. 7.
    Ehrmann, S., andBruenauer, S. R. Sclerodermie. In Jadassohn Handbuch der Hautund Geschlechtskrankheiten 3 Part 2). Springer, Berlin, 1931, p 806.Google Scholar
  8. 8.
    Goetz, R. H. The pathology of progressive systemic sclerosis (generalized scleroderma).Clin Proc 4:337, 1945.Google Scholar
  9. 9.
    O'Leary, P. A., Olsen, A. M., andKirklin, B. R. Esophageal lesions associated with acrosclerosis and scleroderma.AMA Arch Intern Med 76:189, 1945.Google Scholar
  10. 10.
    Beerman, H. The visceral manifestations of scleroderma, a review of the literature.Amer J Med Sci 216:458, 1948.Google Scholar
  11. 11.
    Rodnan, G. P., andBenedek, T. G. A historical account of the study of progressive systemic sclerosis (diffuse scleroderma).Ann Intern Med 57:305, 1962.PubMedGoogle Scholar
  12. 12.
    Kure, K., Yamagata, K., Tsukada, S., andHiyoski, J. Passagestoerung des Oesophagus bei Sklerodermie und Dystrophia Musc.Progressiva. Klin Wschr 25:516, 1936.CrossRefGoogle Scholar
  13. 13.
    Weissenbach, R. V., Steward, W. M., andHoesli, H. Troubles fonctionnels et lesions de l'oesophage dans la sclerodermie.Ann Derm Syph (Par) 9:81 (and 198), 1938.Google Scholar
  14. 14.
    Lorber, S. H., andZarafonetis, C. J. D. Esophageal transport studies in scleroderma.Amer J Med Sci 245:654, 1963.Google Scholar
  15. 15.
    Kramer, P., andIngelfinger, F. J. Motility of the human esophagus in control subjects and in patients with esophageal disorders.Amer J Med 7: 168, 1949.CrossRefGoogle Scholar
  16. 16.
    Code, C. F., Hightower, N. C., andMorlock, G. G. Motility of the alimentary canal in man.Amer J Med 13:328, 1952.CrossRefPubMedGoogle Scholar
  17. 17.
    Dornhorst, A. C., Pierce, J. W., andWhimster, I. W. The oesophageal lesion in scleroderma.Lancet 1:698, 1954.CrossRefGoogle Scholar
  18. 18.
    Creamer, B., Anderson, H. A., andCode, C. F. Esophageal motility in patients with scleroderma and related diseases.Gastroenterologia 86:763, 1956.PubMedGoogle Scholar
  19. 19.
    Code, C. F., Creamer, B., Schlegel, J. F., Olson, A. M., Donoghue, F. E., andAndersen, H. A. An Atlas of Esophageal Motility in Health and Disease. Thomas, Springfield, Ill., 1958.Google Scholar
  20. 20.
    Stevens, M. B., Hookman, P., Siegel, C. I., Esterly, J. R., Shulman, L. E., andHendrix, T. R. Aperistalsis of the esophagus in patients with connective tissue disorders and Raynaud's phenomenon.New Engl J Med 270:1218, 1961.Google Scholar
  21. 21.
    Fyke, F. E., Code, C. F., andSchlegel, J. F. The gastroesophageal sphincter in healthy human beings.Gastroenterologia 86:135, 1956.PubMedGoogle Scholar
  22. 22.
    Code, C. F., andSchlegel, J. F. The pressure profile of the gastroesophageal sphincter in man.An improved method of detection. Proc Mayo Clin 33:406, 1958.Google Scholar
  23. 23.
    Kramer, P., andIngelfinger, F. J. Esophageal sensitivity to Mecholyl in cardiospasm.Gastroenterology 19:242, 1951.PubMedGoogle Scholar
  24. 24.
    Hightower, N. C., Olsen, A., andMoersh, H. J. A comparison of the effects of acetyl-beta-methyl-choline chloride (Mecholyl) on esophageal intraluminal pressure in normal persons and patients with cardiospasm.Gastroenterology 26:592, 1954.PubMedGoogle Scholar
  25. 25.
    Rake, G. On the pathology and pathogenesis of scleroderma.Bull Johns Hopkins Hosp 48:212, 1931.Google Scholar
  26. 26.
    Abrams, H. L., Carnes, W. H., andEaton, J. Alimentary tract in disseminated scleroderma with emphasis on small bowel.AMA Arch Intern Med 94: 61, 1954.PubMedGoogle Scholar
  27. 27.
    Treacy, W. L., Baggenstoss, A. H., Slocumb, C. H., andCode, C. F. Scleroderma of the esophagus. A correlation of histologic and physiologic findings.Ann Intern Med 59:351, 1963.PubMedGoogle Scholar
  28. 28.
    Lindsay, J. R., Templeton, F. E., andRothman, S. Lesions of the esophagus in generalized progressive scleroderma.JAMA 123:145, 1943.Google Scholar
  29. 29.
    Zarafonetis, C. J. D., Lorber, S. H., andHanson, S. M. Association of functioning carcinoid syndrome and scleroderma. I. case report.Amer J Med Sci 236:1, 1958.PubMedGoogle Scholar

Copyright information

© Hoeber Medical Division • Harper & Row, Publishers, Incorporated 1966

Authors and Affiliations

  • Thomas A. Saladin
    • 1
  • Arthur B. French
    • 1
  • Chris J. D. Zarafonetis
    • 1
  • H. Marvin Pollard
    • 1
  1. 1.From the Department of Internal Medicine (Gastroenterology Section and Simpson Memorial Institute)The University of Michigan Medical School, and the Clinical Research Unit of the University of Michigan HospitalAnn Arbor

Personalised recommendations